Cargando…
Inflammatory bowel disease type influences development of elevated liver enzymes
BACKGROUND AND AIM: Up to a third of patients with inflammatory bowel disease (IBD) have elevated liver enzymes (ELE). We evaluated the incidence, predictors, and outcomes associated with ELE in a diverse and vulnerable IBD cohort. METHODS: We retrospectively evaluated 336 IBD patients receiving car...
Autores principales: | Cheng, Yao‐Wen, McLean, Richard, Sewell, Justin L, Huang, Chiung‐Yu, Khalili, Mandana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730719/ https://www.ncbi.nlm.nih.gov/pubmed/36514498 http://dx.doi.org/10.1002/jgh3.12831 |
Ejemplares similares
-
Race and Inflammatory Bowel Disease in an Urban Healthcare System
por: Sewell, Justin L., et al.
Publicado: (2010) -
13-year mortality trends among hospitalized patients with inflammatory bowel disease
por: Sewell, Justin L, et al.
Publicado: (2012) -
Evaluation of Elevated Liver Enzymes
por: Lee, Tae Hoon, et al.
Publicado: (2012) -
Influence of nonalcoholic fatty liver disease on inflammatory bowel disease hospitalizations in the United States
por: Soni, Aakriti, et al.
Publicado: (2023) -
Interleukin-23 in the Pathogenesis of Inflammatory Bowel Disease and Implications for Therapeutic Intervention
por: Sewell, Gavin W, et al.
Publicado: (2022)